glp 1 and migraine Could GLP-1s prevent migraine? A new study of 22,000 chronic patients suggests...maybe. Over 12 months, GLP-1 users vs topiramate users had: >10% fewer ED visits >14% fewer hospitalizations >48% less likely GLP-1 Drugs Tied to Unexpected

In trials, GLP-1 medications also reduce: Non-HDL cholesterol and triglycerides Systolic blood pressure (typically 36 mmHg) High-sensitivity C-reactive protein (hsCRP), a marker of systemic inflammation by as much as 47.7% in ATTAIN-1 [2] HbA1c in patients with type 2 diabetes or prediabetes Early and emerging evidence suggests benefits in other conditions too

GLP-1s have been used to treat T2D since 2005, said Chris Schott, a senior analyst covering the U.S

For the measurement of fecal BAs, 19 euthyroid human study participants were recruited (Supplementary Table 2)

GLP-1 suppresses appetite broadly, but users who are eating less tend to prioritize nutrient density when they do eat